Tyrosine kinase‐altered spindle cell neoplasms with EGFR internal tandem duplications
Authors:
- 10 June 2022
- journal article
- research article
- Published by Wiley in Genes, Chromosomes and Cancer
- Vol. 61 (10) , 616-621
Abstract
In this study, we present two extra‐renal pediatric spindle cell neoplasms with epidermal growth factor receptor (EGFR) internal tandem duplications (ITD). Histologically, these tumors demonstrated the same histologic features seen in other tyrosine kinase‐altered spindle cell neoplasms, with one case showing abundant adipose tissue with cellular fibrous septae resembling lipofibromatosis and the other case showing fascicles of spindled cells resembling infantile fibrosarcoma. There was variable expression of CD34, S100, and SMA, and all cases were negative for panTRK. This case series adds to our molecular understanding of the spectrum of tyrosine kinase‐altered spindle cell neoplasms and represents the first reported examples of EGFR ITDs in extra‐renal tumors. The presence of EGFR alterations in the absence of gene fusions represents a potential therapeutic target and necessitates a broader testing panel for this group of tumors.Keywords
This publication has 15 references indexed in Scilit:
- Recurrent EGFR alterations in NTRK3 fusion negative congenital mesoblastic nephromaPractical Laboratory Medicine, 2020
- The histologic spectrum of soft tissue spindle cell tumors with NTRK3 gene rearrangementsGenes, Chromosomes and Cancer, 2019
- Expanding the Spectrum of Pediatric NTRK-rearranged Mesenchymal TumorsAmerican Journal of Surgical Pathology, 2019
- Recurrent intragenic rearrangements of EGFR and BRAF in soft tissue tumors of infantsNature Communications, 2018
- Lung adenocarcinoma patient with an EGFR kinase domain duplication (KDD) and the response to icotinibJournal of Thoracic Disease, 2018
- Clear cell sarcoma of kidney involving a horseshoe kidney and harboring EGFR internal tandem duplicationPediatric Blood & Cancer, 2017
- EGFR Kinase Domain Duplication (EGFR-KDD) Is a Novel Oncogenic Driver in Lung Cancer That Is Clinically Responsive to AfatinibCancer Discovery, 2015
- Durable Response to Tyrosine Kinase Inhibitor Therapy in a Lung Cancer Patient Harboring Epidermal Growth Factor Receptor Tandem Kinase Domain DuplicationJournal of Thoracic Oncology, 2015
- Oncogenic epidermal growth factor receptor mutants with tandem duplication: gene structure and effects on receptor functionOncogene, 2000
- Tandem duplication of the epidermal growth factor receptor tyrosine kinase and calcium internalization domains in A-172 glioma cellsOncogene, 1998